Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Struktur
865792-18-3
CAS-Nr.
865792-18-3
Englisch Name:
Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
Synonyma:
Cilostazol USP RC C;Cilostazol Impurity 5;Cilostazol Impurity C;Cilostazol impurity II;Cilostazol related coMpound C;CILOSTAZOLE IMPURITY C / RC-C;Cilostazol USP Related Compound C;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohex...;6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one;Cilostazol Related Compound C (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tet (1134186)
CBNumber:
CB02567390
Summenformel:
C31H45N9O2
Molgewicht:
575.75
MOL-Datei:
865792-18-3.mol

Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Eigenschaften

Schmelzpunkt:
43 - 47*C
storage temp. 
Refrigerator, under inert atmosphere
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
Farbe
White to Pale Yellow

Sicherheit

HS Code  2933790002

Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone, is an impurity of Cilostazol (C441500), a potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake.

Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 50)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
sgtlifesciences pvt ltd
+8617013299288
dj@sgtlifesciences.com China 12382 58
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418684 +8618949823763
sales@tnjchem.com China 25363 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39010 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 94658 76
Sinopharm Chemical Reagent Co,Ltd. 86-21-63210123
sj_scrc@sinopharm.com China 9823 79
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5056 50
Shanghai TaoSu Biochemical Technology Co., Ltd. 021-33632979
info@tsbiochem.com China 8072 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 18046 56

  • Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
  • 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone
  • 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-
  • Cilostazol related coMpound C
  • Cilostazol USP Related Compound C
  • 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butyl]-3,4-dihydro-1H-quinolin-2-one
  • 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one
  • Cilostazol USP RC C
  • Cilostazol Impurity 5
  • 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl)-3,4-dihydroquinolin-2(1H)-one
  • 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohex...
  • 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]- 1-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butyl]-1, 2,3,4-tetrahydroquinolin-2-one
  • Cilostazol Related Compound C (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tet (1134186)
  • Cilostazol Impurity C
  • Cilostazol impurity II
  • 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl)-3,4-dihydroquinolin-2(1H)-one (Cilostazol Impurity)
  • CILOSTAZOLE IMPURITY C / RC-C
  • 865792-18-3
  • C31H45N9O2
  • Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
Copyright 2019 © ChemicalBook. All rights reserved